Download FREE Report Sample
Download Free samplePlasma compatibilizer, also known as plasma compatibilizer, plasma substitute, it is a kind of colloidal solution with molecular weight close to the plasma protein, the effect of replacing and expanding the plasma capacity depends on its colloid osmotic pressure after input into the blood vessel.The global market for gelatin polypeptide plasma volume enhancers is highly concentrated. Before 2017, the output share of the nine major enterprises reached 93.72%, and the market scale was 94.71%.The top five enterprises in the market of gelatin polypeptide plasma compatibilizer are Braun medical, Abbott, Wuhan Hualong, Zhejiang Kangle and BBCA Group. Among them, Braun medical is firmly in the top spot, accounting for 46% of production in 2018.
Gelatin-Based Plasma Expander Market contains market size and forecasts of Gelatin-Based Plasma Expander in global, including the following market information:
Global Gelatin-Based Plasma Expander Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gelatin-Based Plasma Expander Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gelatin-Based Plasma Expander companies in 2021 (%)
The global Gelatin-Based Plasma Expander market was valued at 114.3 million in 2021 and is projected to reach US$ 250.6 million by 2028, at a CAGR of 11.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Content of 4.0% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gelatin-Based Plasma Expander include Braun, Abbott, Wuhan Hualong Biological Pharmaceutical Co.,Ltd., Zhejiang Kangle Pharmaceutical Co.,Ltd., China BBCA Group Corporation, Harbin Sanctity Biological Pharmaceutical, Fuzhou Neptunus Futao Pharmaceuticals Co.,Ltd., Dikang and WUHAN DOCAN PHARMACEUTICAL CO.LTD. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gelatin-Based Plasma Expander manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gelatin-Based Plasma Expander Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gelatin-Based Plasma Expander Market Segment Percentages, by Type, 2021 (%)
Content of 4.0%
Content of 3.5%
Content of 3.2%
Global Gelatin-Based Plasma Expander Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gelatin-Based Plasma Expander Market Segment Percentages, by Application, 2021 (%)
Preoperative Prevention
Cardiopulmonary Bypass and Dialysis
Global Gelatin-Based Plasma Expander Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gelatin-Based Plasma Expander Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gelatin-Based Plasma Expander revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gelatin-Based Plasma Expander revenues share in global market, 2021 (%)
Key companies Gelatin-Based Plasma Expander sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gelatin-Based Plasma Expander sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Braun
Abbott
Wuhan Hualong Biological Pharmaceutical Co.,Ltd.
Zhejiang Kangle Pharmaceutical Co.,Ltd.
China BBCA Group Corporation
Harbin Sanctity Biological Pharmaceutical
Fuzhou Neptunus Futao Pharmaceuticals Co.,Ltd.
Dikang
WUHAN DOCAN PHARMACEUTICAL CO.LTD
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy